论文部分内容阅读
目的探讨小儿川崎病的临床诊断特点及有效治疗方法。方法选取2012年2月—2014年1月郑州人民医院收治的小儿川崎病患儿68例,将患儿随机分为观察组和对照组各34例,两组患儿均给予阿司匹林治疗,观察组在此基础上加用丙种球蛋白静脉注射治疗,总结两组患儿的临床特点,并比较疗效。结果经上述治疗后,观察组患儿的退热时间为(26.55±5.73)h,冠状动脉病变的发生几率为5.88%,均明显低于对照组水平,指标的组间比较结果均有明显差异(P<0.05)。结论临床上在治疗小儿川崎病时,可采用阿司匹林联合丙种球蛋白治疗,降低冠状动脉病变的发生几率,改善患儿预后,值得推广使用。
Objective To investigate the clinical features and effective treatment of pediatric Kawasaki disease. Methods Sixty-eight children with Kawasaki disease were admitted to Zhengzhou People’s Hospital from February 2012 to January 2014. The children were randomly divided into observation group (34 cases) and control group (34 cases). Both groups were given aspirin, and the observation group On this basis, plus intravenous gamma globulin treatment, summarize the clinical features of two groups of children, and compare the curative effect. Results After the above treatment, the observation group patients with fever (26.55 ± 5.73) h, the incidence of coronary artery disease was 5.88%, were significantly lower than the control group, the indicators were significantly different between the results (P <0.05). Conclusion In the treatment of pediatric Kawasaki disease, aspirin can be used in combination with gamma globulin to reduce the incidence of coronary artery disease and improve the prognosis of children, which is worth promoting the use of.